OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Palmitoylethanolamide ameliorates neuroinflammation via modulating PPAR-α to promote the functional outcome after intracerebral hemorrhage
Guoyang Zhou, Xiongjie Fu, Liang Wang, et al.
Neuroscience Letters (2022) Vol. 781, pp. 136648-136648
Open Access | Times Cited: 14

Showing 14 citing articles:

PPAR agonists for the treatment of neuroinflammatory diseases
Celene Titus, Md. Tozammel Hoque, Reina Bendayan
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 9-23
Closed Access | Times Cited: 29

Benefits of Camelina sativa Supplementation in Morphine Treatment: Enhanced Analgesia, Delayed Tolerance and Reduced Gut Side Effects Through PPAR-α Receptor Engagement
Elena Lucarini, Eleonora Pagnotta, Laura Micheli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2519-2519
Open Access

Pemafibrate prevents choroidal neovascularization in a mouse model of neovascular age-related macular degeneration
Deokho Lee, Ayaka Nakai, Yukihiro Miwa, et al.
PeerJ (2023) Vol. 11, pp. e14611-e14611
Open Access | Times Cited: 8

Therapeutic Use of Palmitoylethanolamide as an Anti-Inflammatory and Immunomodulator
Maria Clara Inácio de Sá, Marina Gomes Miranda e Castor
Future Pharmacology (2023) Vol. 3, Iss. 4, pp. 951-978
Open Access | Times Cited: 4

Palmitoylethanolamide, an endogenous fatty acid amide, and its pleiotropic health benefits: A narrative review
Debapriya Basu
Journal of Biomedical Research (2024) Vol. 38, pp. 1-1
Open Access | Times Cited: 1

Palmitoylethanolamide in Postmenopausal Metabolic Syndrome: Current Evidence and Clinical Perspectives
Alessandro Medoro, Sergio Davinelli, Federica Fogacci, et al.
Nutrients (2024) Vol. 16, Iss. 24, pp. 4313-4313
Open Access | Times Cited: 1

Palmitoylethanolamide and Related ALIAmides for Small Animal Health: State of the Art
Giorgia Della Rocca, Re G
Biomolecules (2022) Vol. 12, Iss. 9, pp. 1186-1186
Open Access | Times Cited: 4

Gypenoside XLIX alleviates sepsis-associated encephalopathy by targeting PPAR-α
Panpan Zhao, Wei Zhang, Xinyu Zhou, et al.
Experimental Neurology (2024) Vol. 383, pp. 115027-115027
Closed Access

Evaluation of N-palmitoylethanolamine (PEA) binding to nuclear receptors through docking and molecular dynamics studies
Fakher Frikha, Sami Aifa
Computers in Biology and Medicine (2024) Vol. 184, pp. 109421-109421
Closed Access

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosis in vivo
Melissa E. Munzen, Marta Reguera Gomez, Mohamed F. Hamed, et al.
Antimicrobial Agents and Chemotherapy (2023) Vol. 67, Iss. 10
Open Access | Times Cited: 1

Palmitoylethanolamide shows limited efficacy in controlling cerebral cryptococcosisin vivo
Melissa E. Munzen, Marta Reguera-Gómez, Mohamed F. Hamed, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Page 1

Scroll to top